1 Introduction to Research & Analysis Reports
1.1 Needle-Free Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Needle-Free Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Needle-Free Influenza Vaccine Overall Market Size
2.1 Global Needle-Free Influenza Vaccine Market Size: 2022 VS 2029
2.2 Global Needle-Free Influenza Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Needle-Free Influenza Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Needle-Free Influenza Vaccine Players in Global Market
3.2 Top Global Needle-Free Influenza Vaccine Companies Ranked by Revenue
3.3 Global Needle-Free Influenza Vaccine Revenue by Companies
3.4 Global Needle-Free Influenza Vaccine Sales by Companies
3.5 Global Needle-Free Influenza Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Needle-Free Influenza Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Needle-Free Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Needle-Free Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Needle-Free Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Needle-Free Influenza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Needle-Free Influenza Vaccine Market Size Markets, 2022 & 2029
4.1.2 Live Attenuated Influenza Vaccine
4.1.3 Split Influenza Vaccine
4.2 By Type – Global Needle-Free Influenza Vaccine Revenue & Forecasts
4.2.1 By Type – Global Needle-Free Influenza Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Needle-Free Influenza Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Needle-Free Influenza Vaccine Sales & Forecasts
4.3.1 By Type – Global Needle-Free Influenza Vaccine Sales, 2018-2023
4.3.2 By Type – Global Needle-Free Influenza Vaccine Sales, 2024-2029
4.3.3 By Type – Global Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Needle-Free Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Needle-Free Influenza Vaccine Market Size, 2022 & 2029
5.1.2 3-17 Years
5.1.3 Others
5.2 By Application – Global Needle-Free Influenza Vaccine Revenue & Forecasts
5.2.1 By Application – Global Needle-Free Influenza Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Needle-Free Influenza Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Needle-Free Influenza Vaccine Sales & Forecasts
5.3.1 By Application – Global Needle-Free Influenza Vaccine Sales, 2018-2023
5.3.2 By Application – Global Needle-Free Influenza Vaccine Sales, 2024-2029
5.3.3 By Application – Global Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Needle-Free Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Needle-Free Influenza Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Needle-Free Influenza Vaccine Revenue & Forecasts
6.2.1 By Region – Global Needle-Free Influenza Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Needle-Free Influenza Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Needle-Free Influenza Vaccine Sales & Forecasts
6.3.1 By Region – Global Needle-Free Influenza Vaccine Sales, 2018-2023
6.3.2 By Region – Global Needle-Free Influenza Vaccine Sales, 2024-2029
6.3.3 By Region – Global Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Needle-Free Influenza Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Needle-Free Influenza Vaccine Sales, 2018-2029
6.4.3 US Needle-Free Influenza Vaccine Market Size, 2018-2029
6.4.4 Canada Needle-Free Influenza Vaccine Market Size, 2018-2029
6.4.5 Mexico Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Needle-Free Influenza Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Needle-Free Influenza Vaccine Sales, 2018-2029
6.5.3 Germany Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.4 France Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.5 U.K. Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.6 Italy Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.7 Russia Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.9 Benelux Needle-Free Influenza Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Needle-Free Influenza Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Needle-Free Influenza Vaccine Sales, 2018-2029
6.6.3 China Needle-Free Influenza Vaccine Market Size, 2018-2029
6.6.4 Japan Needle-Free Influenza Vaccine Market Size, 2018-2029
6.6.5 South Korea Needle-Free Influenza Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Needle-Free Influenza Vaccine Market Size, 2018-2029
6.6.7 India Needle-Free Influenza Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Needle-Free Influenza Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Needle-Free Influenza Vaccine Sales, 2018-2029
6.7.3 Brazil Needle-Free Influenza Vaccine Market Size, 2018-2029
6.7.4 Argentina Needle-Free Influenza Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Needle-Free Influenza Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Needle-Free Influenza Vaccine Sales, 2018-2029
6.8.3 Turkey Needle-Free Influenza Vaccine Market Size, 2018-2029
6.8.4 Israel Needle-Free Influenza Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Needle-Free Influenza Vaccine Market Size, 2018-2029
6.8.6 UAE Needle-Free Influenza Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Needle-Free Influenza Vaccine Major Product Offerings
7.1.4 AstraZeneca Needle-Free Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Cipla
7.2.1 Cipla Company Summary
7.2.2 Cipla Business Overview
7.2.3 Cipla Needle-Free Influenza Vaccine Major Product Offerings
7.2.4 Cipla Needle-Free Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Cipla Key News & Latest Developments
7.3 BCHT
7.3.1 BCHT Company Summary
7.3.2 BCHT Business Overview
7.3.3 BCHT Needle-Free Influenza Vaccine Major Product Offerings
7.3.4 BCHT Needle-Free Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 BCHT Key News & Latest Developments
8 Global Needle-Free Influenza Vaccine Production Capacity, Analysis
8.1 Global Needle-Free Influenza Vaccine Production Capacity, 2018-2029
8.2 Needle-Free Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Needle-Free Influenza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Needle-Free Influenza Vaccine Supply Chain Analysis
10.1 Needle-Free Influenza Vaccine Industry Value Chain
10.2 Needle-Free Influenza Vaccine Upstream Market
10.3 Needle-Free Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Needle-Free Influenza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Needle-Free Influenza Vaccine in Global Market
Table 2. Top Needle-Free Influenza Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Needle-Free Influenza Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Needle-Free Influenza Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Needle-Free Influenza Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Needle-Free Influenza Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Needle-Free Influenza Vaccine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Needle-Free Influenza Vaccine Product Type
Table 9. List of Global Tier 1 Needle-Free Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Needle-Free Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Needle-Free Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Needle-Free Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Needle-Free Influenza Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Needle-Free Influenza Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Needle-Free Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Needle-Free Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Needle-Free Influenza Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Needle-Free Influenza Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Needle-Free Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Needle-Free Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Needle-Free Influenza Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Needle-Free Influenza Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Needle-Free Influenza Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Needle-Free Influenza Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Needle-Free Influenza Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Needle-Free Influenza Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Needle-Free Influenza Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Needle-Free Influenza Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Needle-Free Influenza Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Needle-Free Influenza Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Needle-Free Influenza Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Needle-Free Influenza Vaccine Sales, (K Units), 2024-2029
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Needle-Free Influenza Vaccine Product Offerings
Table 48. AstraZeneca Needle-Free Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Cipla Company Summary
Table 51. Cipla Needle-Free Influenza Vaccine Product Offerings
Table 52. Cipla Needle-Free Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Cipla Key News & Latest Developments
Table 54. BCHT Company Summary
Table 55. BCHT Needle-Free Influenza Vaccine Product Offerings
Table 56. BCHT Needle-Free Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. BCHT Key News & Latest Developments
Table 58. Needle-Free Influenza Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 59. Global Needle-Free Influenza Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Needle-Free Influenza Vaccine Production by Region, 2018-2023 (K Units)
Table 61. Global Needle-Free Influenza Vaccine Production by Region, 2024-2029 (K Units)
Table 62. Needle-Free Influenza Vaccine Market Opportunities & Trends in Global Market
Table 63. Needle-Free Influenza Vaccine Market Drivers in Global Market
Table 64. Needle-Free Influenza Vaccine Market Restraints in Global Market
Table 65. Needle-Free Influenza Vaccine Raw Materials
Table 66. Needle-Free Influenza Vaccine Raw Materials Suppliers in Global Market
Table 67. Typical Needle-Free Influenza Vaccine Downstream
Table 68. Needle-Free Influenza Vaccine Downstream Clients in Global Market
Table 69. Needle-Free Influenza Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Needle-Free Influenza Vaccine Segment by Type in 2022
Figure 2. Needle-Free Influenza Vaccine Segment by Application in 2022
Figure 3. Global Needle-Free Influenza Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Needle-Free Influenza Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Needle-Free Influenza Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Needle-Free Influenza Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Needle-Free Influenza Vaccine Revenue in 2022
Figure 9. By Type - Global Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Needle-Free Influenza Vaccine Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Needle-Free Influenza Vaccine Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Needle-Free Influenza Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
Figure 23. US Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
Figure 37. China Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Needle-Free Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Needle-Free Influenza Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Needle-Free Influenza Vaccine by Region, 2022 VS 2029
Figure 54. Needle-Free Influenza Vaccine Industry Value Chain
Figure 55. Marketing Channels
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
